title: Aprotinin and vein graft occlusion--the controversy continues.
authors.forename: S
authors.initials: S
authors.lastname: Westaby
authors.forename: T
authors.initials: T
authors.lastname: Katsumata
mesh_terms: D007611:Aprotinin / Q000008:administration & dosage / Q000009:adverse effects*; D001026:Coronary Artery Bypass; D006083:Graft Occlusion, Vascular / Q000139:chemically induced* / Q000401:mortality; D006490:Hemostatics / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D015996:Survival Rate; D014680:Veins / Q000637:transplantation
chemical_list: D006490:Hemostatics; D007611:Aprotinin